Prolongation of survival of alloskin grafts with no concurrent general suppression of the burned patient's immune system: A preliminary clinical investigation

Burns

Volumn 22, Issue 5, 1996, Pages 353-358

  Wu, J ^a,c,d   Barisoni, D ^b,c   Armato, U ^a,c,e  

^a UNIVERSITY OF VERONA   (Italy)

^b Verona Major Hospital   (Italy)

^c Venetian Region's Ctr for the S   (Italy)

^d SOUTHWEST HOSPITAL   (China)

^e Institute of Anatomy and Histology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ARTICLE; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; SKIN ALLOGRAFT; ULTRAVIOLET IRRADIATION; WOUND HEALING; WOUND INFECTION;

EID: 0030222218     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-4179(95)00159-X     Document Type: Article

References (39)

1. 1 Burke JF, Yannas IV, Quinby WC, Bondoc CC, Jung AX. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413-428.
2. 2 Hansbrough JF, Boyce ST, Cooper ML, Foreman TJ. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen glycosaminoglycan substrate. JAMA 1989; 262: 2125-2130.
3. 3 Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6: 331-344.
4. 4 Hermans MHE. Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns. Burns 1989; 15: 57-59.
5. 5 Kreis RW, Hoekstra MJ, Mackie DP, Vloemans AFPM, Hermans RP. Historical appraisal of the use of skin allografts in the treatment of extensive full skin thickness burns at the Red Cross Hospital Burns Centre, Beverwijk, The Netherlands. Burns 1992; 18: (suppl 2), S19-S22.
6. 6 Dhennin C. Skin allografts in burns: a French national survey. In: Abstract Book of European Burn Association 5th Congress, 1994; pC5.
7. + T cell subsets. Transplantation 1986; 41: 634-639.
8. 8 Aubock J, Irschick E, Romani N et al. Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans. Transplantation 1988; 45: 730-737.
9. 9 Streinbruchel D, Kemp E, Starklint H, Dieperink H. Synergistic effect of cyclosporine A, cyclophosphamide, and steroids in rabbit-to-rat skin xenotransplantation. Transplant Proc 1987; 19: 1168-1170.
10. 10 Lagodzinski Z, Gorski A, Wasik M. Effect of FK-506 and cyclosporine on primary and secondary skin allograft survival in mice. Immunology 1990; 71: 148-150.
11. 11 Eng CP, Gullo-Brown J, Chang JY, Sehgal SN. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide. Transplant Proc 1991; 23: 868-869.
12. 12 Schorlemmer HU, Dickneite G, Seiler FR. Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualin. Transplant Proc 1990; 22: 1626-1630.
13. 13 Wood KJ, Bushell AR, Darby CR, Pearson TC, West L, Morris PJ. Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody. Transplant Proc 1991; 23: 133-134.
14. 14 Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerated in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990; 20: 2747-2755.
15. 15 Hamelmann E, Wottge HU, Gassmann W, Uharek L, Muller-Ruchnoltz W. Inducation of tolerance after facilitation of engraftment with a monoclonal antibody anti-MHC class II fully allogeneic transplantation. Transplant Proc 1990; 22: 2340-2341.
16. 16 Greger B, Hebart H, Busing M, Hopt UT, Lauchart W. Induction of alloreactive suppressor cells by rabbit-derived anti-idiotypic antibodies. Transplant Proc 1991; 23: 2250.
17. 17 Alsbjorn B, Sorensen B. Grafting with epidermal Langerhans cell depressed cadaver split skin. Burns 1985; 11: 259-263.
18. 18 Ingham E, Matthews JB, Kearney JN, Gowland G. The effects of variation of cryo-preservation protocols on the immunogenicity of allogeneic skin grafts. Cryobiology 1993; 30: 443-458.
19. 19 Wu J, Barisoni D, Menapace L, Ribecco M, Armato U. A novel approach to extend the survival of skin xenografts without entailing general immunosuppression or systemic toxicity. Burns 1993; 19: 289-296.
20. 20 Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991; 252: 1700-1702.
21. 21 Baker D, Parker DD, Turk JL. Effect of depletion of epidermal dendritic cells on the induction of contact sensitivity in the guinea-pig. Br J Dermatol 1985; 113: 285-294.
22. 22 Freshney RI. Specialized techniques. In: Freshney RI (ed) Culture of Animal Cells, 3rd edn. New York: Alan R Liss, 1994; p 369.
23. 23 Czernielewski JM, Vaigot P, Schmitt D, Prunieras M. Mixed skin cell-lymphocyte culture reaction (MSLR) in man as an in vitro model of lympho-epidermal interactions: FACS analysis of epidermal cell and T-cell involved subpopulations. Br J Dermatol 1984; 111: (suppl 27), 228-231.
24. 24 Faure M, Schmitt D, Dezutter-Dambuyant C, Frappaz A, Gaucherand M, Thivolet J. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells. Br J Dermatol 1984; 111: (suppl 27), 11-27.
25. 2-microglobulin monoclonal antibody prevents the reactive proliferation of lymphocytes elicited by allo-human-epidermal cells. J Immunol Res 1992; 4: 21-26.
26. 26 Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. The immune system. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (eds) Molecular Biology of the Cell, 3rd edn. New York: Garland, 1994; pp 1195-1254.
27. 27 Unanue ER. Cellular studies on antigen presentation by class II MHC molecules. Curr Opin Immunol 1992; 4: 63-69.
28. 28 Fisher JC. Skin - the ultimate solution for the burn wound. New Engl J Med 1984; 311: 466-467.
29. 29 Chouaib S, Welte K, Dupont B. Differential effect of anti-b2-microglobulin on IL 2 production and IL 2 receptor expression in the primary mixed lymphocyte culture reaction. J Immunol 1985; 134: 940-948.
30. 30 Metlay JP, Pure E, Steinman RM. Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes. Adv Immunol 1989; 47: 45-116.
31. 31 Weaver CT, Unanue ER. The costimulatory function of antigen-presenting cells. Immunol Today 1990; 11: 49-55.
32. 32 Wu J, Barisoni D, Armato U. Donor's and recipient's antigen presenting cells cooperatively enhance the allo-reactive proliferation of peripheral blood lymphocytes. Life Sci 1994; 54: 1009-1017.
33. 33 Saunder DN, Noonan FP, DeFabo EC, Katz SI. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). J Invest Dermatol 1983; 80: 485-489.
34. 34 Nithiuthai S, Allen JR. Effects of ultraviolet irradiation on epidermal Langerhans cells in guinea-pigs. Immunology 1984; 51: 143-151.
35. 35 Vermeer BJ, Santerse B, Van De Kerckhove BAE, Schothorst AA, Claas FHJ. Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts. Transplantation 1988; 45: 607-610.
36. 36 Granstein RD. Ultraviolet radiation effects on immunologic function. Reg Immunol 1990; 3: 112-119.
37. 37 Larsen CP, Austyn JM. Langerhans cells migrate out of skin grafts and cultured skin: a model in which to study the mediators of dendritic leukocyte migration. Transplant Proc 1991; 23: 117-119.
38. 38 Noonan FP, De Fabo EC, Morrison H. Cis-urocanic acid, a product formed by ultraviolet B irradiation of the skin, initiates an antigen presentation defect in splenic dendritic cells in vivo. J Invest Dermatol 1988; 90: 92-99.
39. 39 Moore KW, O'Garra A, Malefyt RW, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.